Lumen Bioscience Awarded Federal Funding to Advance Covid-19 Antibody Cocktail through Phase 2 Clinical Evaluation

by admin | Oct 5, 2021 | Press Release

Project to support full Phase 2 trial, GMP manufacturing scale-up Seattle, WA, October 6, 2021 – Lumen Bioscience—a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases—today announced new development funding from the US...

Lumen Bioscience Launches Phase 1 Trial of Oral Biologic Drug for Preventing C. difficile Infection Recurrence

by admin | Aug 31, 2021 | Press Release

— First-in-human trial studying LMN-201 enteric capsules underway in Australia Seattle, WA, September 1, 2021 – Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced the start of a Phase 1...

Seattle startup Lumen Bioscience is working with Google to make drugs using algae

by admin | Aug 11, 2021 | Press Release

Plant-Based Biologics All the Rage as Lumen Partners with Google

by admin | Aug 11, 2021 | Press Release

Lumen Bioscience Teams with Google to Apply Machine Learning to Biologics Manufacturing

by admin | Aug 10, 2021 | Press Release

— Application of ML Technology to Double Biomanufacturing Productivity — $2M Grant New Funding from U.S. Depart. of Energy to Support Further Development Seattle, WA, August 11, 2021 – Lumen Bioscience, a clinical-stage biopharmaceutical company developing products to...

Lumen plots site at nearby Seattle bakery as it ramps up production of algae-based biologics

by admin | Jul 23, 2021 | Press Release